WHO to restart Covid drug trial with focus on immune responses
"You need at least promising signals that some of them will work. And we need to study drugs that we can deliver in a broad group of countries,"
"You need at least promising signals that some of them will work. And we need to study drugs that we can deliver in a broad group of countries,"
